Toward Personalization of Asthma Treatment According to Trigger Factors

Asthma is a severe and chronic disabling disease affecting more than 300 million people worldwide. Although in the past few drugs for the treatment of asthma were available, new treatment options are currently emerging, which appear to be highly effective in certain subgroups of patients. Accordingly, there is a need for biomarkers that allow selection of patients for refined and personalized treatment strategies. Recently, serological chip tests based on microarrayed allergen molecules and peptides derived from the most common rhinovirus strains have been developed, which may discriminate 2 of the most common forms of asthma, that is, allergen- and virus-triggered asthma. In this perspective, we argue that classification of patients with asthma according to these common trigger factors may open new possibilities for personalized management of asthma.

Citing Articles

Association between asthma and IgG levels specific for rhinovirus and respiratory syncytial virus antigens in children and adults.

Mauclin M, Guillien A, Niespodziana K, Boudier A, Schlederer T, Bajic M J Allergy Clin Immunol Glob. 2024; 4(1):100342.

PMID: 39507925 PMC: 11536052. DOI: 10.1016/j.jacig.2024.100342.

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC).

Caminati M, Brussino L, Carlucci M, Carlucci P, Carpagnano L, Caruso C Cells. 2024; 13(14.

PMID: 39056762 PMC: 11274683. DOI: 10.3390/cells13141180.

Current Challenges in Pediatric Asthma.

Miculinic A, Mrkic Kobal I, Kusan T, Turkalj M, Plavec D Children (Basel). 2024; 11(6).

PMID: 38929213 PMC: 11201822. DOI: 10.3390/children11060632.

Outdoor aeroallergen impacts on asthma exacerbation among sensitized and nonsensitized Philadelphia children.

De Roos A, Senter J, Schinasi L, Huang W, Moore K, Maltenfort M J Allergy Clin Immunol Glob. 2024; 3(3):100248.

PMID: 38645670 PMC: 11024998. DOI: 10.1016/j.jacig.2024.100248.

Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma.

Naumova V, Beltyukov E, Niespodziana K, Errhalt P, Valenta R, Karaulov A Front Immunol. 2022; 13:941492.

PMID: 36211434 PMC: 9533054. DOI: 10.3389/fimmu.2022.941492.

References

Wickman M, Lupinek C, Andersson N, Belgrave D, Asarnoj A, Benet M . Detection of IgE Reactivity to a Handful of Allergen Molecules in Early Childhood Predicts Respiratory Allergy in Adolescence. EBioMedicine. 2017; 26:91-99. PMC: 5832567. DOI: 10.1016/j.ebiom.2017.11.009. View

Bossios A, Gourgiotis D, Skevaki C, Saxoni-Papageorgiou P, Lotvall J, Psarras S . Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. Clin Exp Allergy. 2008; 38(10):1615-26. DOI: 10.1111/j.1365-2222.2008.03058.x. View

Jackson D, Evans M, Gangnon R, Tisler C, Pappas T, Lee W . Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2011; 185(3):281-5. PMC: 3297109. DOI: 10.1164/rccm.201104-0660OC. View

Niespodziana K, Napora K, Cabauatan C, Focke-Tejkl M, Keller W, Niederberger V . Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J. 2011; 26(3):1001-8. DOI: 10.1096/fj.11-193557. View

Rabe K, Vermeire P, Soriano J, Maier W . Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2001; 16(5):802-7. DOI: 10.1183/09031936.00.16580200. View

Nakauchi M, Nagata N, Takayama I, Saito S, Kubo H, Kaida A . Propagation of Rhinovirus C in Differentiated Immortalized Human Airway HBEC3-KT Epithelial Cells. Viruses. 2019; 11(3). PMC: 6466094. DOI: 10.3390/v11030216. View

Green R, Custovic A, Sanderson G, Hunter J, Johnston S, Woodcock A . Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002; 324(7340):763. PMC: 100316. DOI: 10.1136/bmj.324.7340.763. View

Martinez F, Wright A, Taussig L, Holberg C, Halonen M, Morgan W . Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995; 332(3):133-8. DOI: 10.1056/NEJM199501193320301. View

Seth D, Saini S, Poowuttikul P . Pediatric Inner-City Asthma. Pediatr Clin North Am. 2019; 66(5):967-979. DOI: 10.1016/j.pcl.2019.06.012. View

10.

Chung K, Adcock I . Precision medicine for the discovery of treatable mechanisms in severe asthma. Allergy. 2019; 74(9):1649-1659. DOI: 10.1111/all.13771. View

11.

Skrindo I, Lupinek C, Valenta R, Hovland V, Pahr S, Baar A . The use of the MeDALL-chip to assess IgE sensitization: a new diagnostic tool for allergic disease?. Pediatr Allergy Immunol. 2015; 26(3):239-246. PMC: 6597352. DOI: 10.1111/pai.12366. View

12.

Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U . Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet. 2006; 368(9537):763-70. DOI: 10.1016/S0140-6736(06)69286-6. View

13.

Holt P, Sly P . Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med. 2012; 18(5):726-35. DOI: 10.1038/nm.2768. View

14.

Contreras R, Wilson A, Garavito F, Sexton J, Reynolds K, Canales R . Assessing virus infection probability in an office setting using stochastic simulation. J Occup Environ Hyg. 2019; 17(1):30-37. DOI: 10.1080/15459624.2019.1691219. View

15.

Zhou S, Lukula S, Chiossone C, Nims R, Suchmann D, Ijaz M . Assessment of a respiratory face mask for capturing air pollutants and pathogens including human influenza and rhinoviruses. J Thorac Dis. 2018; 10(3):2059-2069. PMC: 5906272. DOI: 10.21037/jtd.2018.03.103. View

16.

Cipriani F, Calamelli E, Ricci G . Allergen Avoidance in Allergic Asthma. Front Pediatr. 2017; 5:103. PMC: 5423906. DOI: 10.3389/fped.2017.00103. View

17.

Froidure A, Mouthuy J, Durham S, Chanez P, Sibille Y, Pilette C . Asthma phenotypes and IgE responses. Eur Respir J. 2015; 47(1):304-19. DOI: 10.1183/13993003.01824-2014. View

18.

Lee H, Ryu J, Nam E, Chung S, Yeo Y, Park D . Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study. Eur Respir J. 2019; 54(5). DOI: 10.1183/13993003.00804-2019. View

19.

Heffler E, Paoletti G, Giorgis V, Puggioni F, Racca F, Del Giacco S . Real-life studies of biologics used in asthma patients: key differences and similarities to trials. Expert Rev Clin Immunol. 2019; 15(9):951-958. DOI: 10.1080/1744666X.2019.1653758. View

20.

Johnston S, Pattemore P, SANDERSON G, Smith S, Campbell M, Josephs L . The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. 1996; 154(3 Pt 1):654-60. DOI: 10.1164/ajrccm.154.3.8810601. View